Sildenafil Citrate Tablet, Film Coated
Product Images NDC 82009-093

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 82009-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers can be observed in Figure 5.*

FDA Label Image

100mg (Sildenafil 100mg)

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Percentage patients reporting improvement: 4%, 63%, 24%, 2%. The patients were given either placebo, Sidenail tablets, or Sideral tablets (25mg). Sitdari tablets were also included in the evaluation.*

FDA Label Image

Logo (Sildenafil Logo)

FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.